SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

$CAW.X is trending as the community rallies around the memecoin, highlighting its presence on multiple chains and unique burn mechanism. The "crow with knife" meme is central to the conversation, with many expressing bullish sentiment and urging others to join the "caWmunity."

"What's Updog?" is a Community Led token.

UpDog

$UPDOG.X is trending as community members playfully engage with the classic 'What's UpDog?' joke, driving social media buzz and highlighting the token's presence on the Solana network; the community emphasizes its long-term development, locked liquidity, and meme-driven appeal. Some users are drawing comparisons to other popular meme coins, suggesting it could be the next big thing in the crypto space.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as the community debates its next move, with some anticipating a breakout to new highs while others foresee a potential pullback. Discussions revolve around identifying key support levels and the influence of large players, including institutions and whales, on price action. Many are expressing bullish sentiment, urging others to accumulate more Bitcoin and dismiss concerns about short-term price fluctuations.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending amid discussions about potential ETF approvals in October and its role in global finance, with some anticipating significant price movement. Community members are debating its potential to replace SWIFT, while others are focused on technical analysis and potential accumulation zones. Recent news about Ripple's partnerships and integrations within treasury and payment systems are also contributing to the conversation.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as investors analyze its latest portfolio moves, including a reduced stake in Apple and a new investment in UnitedHealth. Community members are debating whether these moves signal a shift in investment strategy or a reaction to market conditions. Some are pointing to the 'Buffett Indicator,' suggesting the market is overvalued, while others are speculating on the 'mystery stock' to be revealed in the upcoming 13F filing.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors discuss the upcoming earnings report and potential for a significant stock move, while some community members speculate about ticker suppression on Stocktwits. Optimism is fueled by BlackBerry's partnerships and potential in AI-driven cybersecurity and EV/IoT sectors. Discussions also include potential buyback programs and a possible acquisition.

Aventus Network

Aventus Network ($AVT.X) is trending as traders discuss its strong chart setup, low market cap, and potential breakout, with some pointing to real-world partnerships and integration with Polkadot as catalysts. Community members are closely monitoring volume, anticipating a significant price movement, and highlighting its potential within the broader altcoin market.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals is trending due to recent positive topline results from its Phase 2 study of zelicapavir in children with RSV, with the community actively discussing the drug's potential and possible partnership opportunities. Some are optimistic about the stock's upside, especially given the small market cap and focus on RSV, while others are waiting for further analysis of the data.

JFB Construction Holdings is a commercial and residential real estate construction and development company, which engages in delivering services to commercial and residential markets. It operates through the following segments: Commercial Construction, Residential Construction, and Real Estate Development. The Commercial Construction segment includes all activities related to the construction of commercial properties. The Residential Construction segment focuses on the construction of residential properties including single-family homes and multi-family units. The Real Estate Development segment refers to the acquisition, development, and sale of real estate properties. The company was founded by Joseph F. Basille III on April 9, 2024 and is headquartered in Lantana, FL.

JFB Construction Holdings - Ordinary Shares - Class A

JFB is trending after announcing a $44M private financing deal, which the community is actively discussing in relation to its potential impact on working capital and future opportunities. Some traders are watching the stock for continuation, while others are concerned about potential dilution from the terms of the deal. The new Stocktwits board is also generating excitement as traders analyze the stock's recent price action.

HA Sustainable Infrastructure Capital, Inc. engages in investing in climate solutions and the provision of capital to assets developed by companies in energy efficiency, renewable energy, and other sustainable infrastructure markets. It focuses on Behind the Meter, Grid-Connected, Fuels, Transport, and Nature climate solutions. The company was founded on November 7, 2012 and is headquartered in Annapolis, MD.

HA Sustainable Infrastructure Capital Inc.

Hannon Armstrong Sustainable Infrastructure capital Inc

HASI is trending as investors assess its potential in the clean energy sector amid growing AI data center energy needs, while also reacting to recent analyst ratings adjustments. Community members are discussing the company's strategy in advanced nuclear, hydrogen, and fuel cells, alongside the potential impacts of policy changes. Recent JP Morgan and Baird ratings are contributing to the increased attention around Hannon Armstrong.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oric Pharmaceuticals, Inc. (ORIC) Now Trades Above Golden Cross: Time to Buy?

When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?

Oric Pharmaceuticals, Inc. (ORIC) is a Great Momentum Stock: Should You Buy?

Does Oric Pharmaceuticals, Inc. (ORIC) have what it takes to be a top stock pick for momentum investors? Let's find out.

All You Need to Know About Oric Pharmaceuticals (ORIC) Rating Upgrade to Buy

Does Oric Pharmaceuticals (ORIC) Have the Potential to Rally 104.99% as Wall Street Analysts Expect?

What Makes Oric Pharmaceuticals, Inc. (ORIC) a Strong Momentum Stock: Buy Now?

Wall Street Analysts Predict a 131.33% Upside in Oric Pharmaceuticals (ORIC): Here's  What You Should Know

Oric Pharmaceuticals' stock hit its highest levels in three months on Thursday after the company unveiled promising preliminary results from its Phase 1b trial of ORIC-944, an AR inhibitor for metastatic castration-resistant prostate cancer (mCRPC).Shares of the pharma company soared 33.5% to close at $7.97 on Thursday.&nbsp;The company said that the trial showed potentially strong performance in both efficacy and safety, as 59% of patients reached a PSA50 response rate.&nbsp;This means that over half of the study participants saw an over 50% reduction in prostate-specific antigen (PSA) levels.Nearly all of these PSA responses were confirmed, and 24% of patients achieved PSA90 responses, indicating a 90% drop in PSA levels.The drug was tested with two established AR inhibitors — apalutamide (Erleada) and darolutamide (Nubeqa) — and PSA responses were consistent across all doses and both combinations.&nbsp;Most patients remained on therapy, with several approaching or surpassing one year of treatment duration.The safety profile was favorable because most adverse events were categorized as Grade 1 or 2.&nbsp;A single Grade 3 diarrhea event occurred, while no Grade 4 or 5 treatment-related events were linked to the medication.Meanwhile, ORIC also announced a $125 million private placement, which it said would extend its cash runway into the second half of 2027, covering the expected readout of its first global Phase 3 trial in 1H 2026.The initiation of ORIC's global registrational Phase 3 trial for ORIC-944 is planned for the first half of 2026.On Stocktwits, retail sentiment was ‘extremely bullish’ amid a 194% surge in 24-hour message volume.One user expressed optimism about the stock soon reaching $10 again.&nbsp;<stembedurl>https://stocktwits.com/OK78/message/616104324</stembedurl>However, another user questioned the private placement, suggesting it might be a setup for short sellers.They cited concerns over the company’s recent $125 million PIPE financing last year, which was initially expected to last through late 2026.&nbsp;“So, in the period of 12 months, they've diluted the stock with $250 million of new shares.”<stembedurl>https://stocktwits.com/Any_Day_Now/message/616156552</stembedurl>The stock has declined 3.5% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Portrait of a doctor woman on the background of stock charts. | Image source: Getty Images

Oric Pharma Stock Hits 3-Month High On Promising Results In Prostate Cancer Trial

The company also announced a $125 million private placement to fund its upcoming Phase 3 trial for ORIC-944 in metastatic prostate cancer.

Equity

ORIC Stock Surges on Upbeat Initial Data From Prostate Cancer Study

Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year

Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year PR Newswire VANCOUVER, BC, Jan. 15, 2025 Issued on behalf...

OpenBench and ORIC Pharmaceuticals Launch Success-Driven Discovery Collaboration

OpenBench and ORIC Pharmaceuticals Launch Success-Driven Discovery Collaboration OpenBench and ORIC Pharmaceuticals Launch Success-Driven Discovery Collaboration PR Newswire SAN FRANCISCO, Sept. 17...

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.

ORIC Pharmaceuticals Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

ORIC
ORIC Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ORIC News

ORIC ORIC Pharmaceuticals Inc